Idaho Urologic Institute
Meridian, Idaho 83642
1 studies enrolling now · 17 studies all time
What they study most
Bladder Cancer, Castration-Resistant Prostate Cancer, Cystitis, Interstitial, Enteric Hyperoxaluria, Healthy Volunteers, Nephrolithiasis, Overactive Bladder, Overactive Bladder With Urinary Incontinence, Painful Bladder Syndrome, Peyronie's Disease, Prostate Cancer, Prostate Cancer (Adenocarcinoma)
Studies at this site
- Prostate Cancer Risk Identification in a Multi-Ethnic Cohort: a Prospective US-based Multi-center Validation Study of Proclarix — Recruiting now
- A Study of Apalutamide (Adjuvant Treatment) and Androgen Deprivation Therapy (ADT) in Participants Who Have Undergone Radical Prostatectomy (RP) for Non-metastatic Prostate Cancer and Who Are at High Risk for Metastases — Completed
- Registry to Evaluate Long-Term Outcomes in Patients Who Undergo 68-Ga-PSMA-11 PET/CT Imaging Evaluations — Stopped early
- Composur: Study to Understand the Performance of Vibegron in Participants with Overactive Bladder (OAB) — Completed
- Study to Evaluate the Efficacy, Safety and Tolerability of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic Hyperplasia (BPH) — Completed
- Urine Sample Collection for Validation of the AnchorDx UriFind™ Bladder Cancer Assay — Paused
- Safety, Tolerability, and Pharmacodynamics of NOV-001 in Adult Subjects — Stopped early
- Establishing the Safety and Efficacy of Reloxaliase in Patients With Enteric Hyperoxaluria — Stopped early
- BOTOX® Intravesical Instillation in Participants With Overactive Bladder and Urinary Incontinence — Completed
- The Cxbladder Monitoring Study — Completed
- Clinical Evaluation of a Test for Monitoring the Recurrence of Bladder Cancer — Completed
- Positive Imaging Study for Distant Metastases in Patients With Castration-Resistant Prostate Cancer — Stopped early
- Efficacy and Safety of Using MPC-5971 in Subjects Undergoing Shock Wave Lithotripsy — Stopped early
- Long-term Safety, Curvature Deformity Characterization, and Immunogenicity Over Time in Subjects Previously Treated With AA4500 for Peyronies Disease — Completed
- A Safety and Efficacy Study of LiRIS® in Females With Interstitial Cystitis/Bladder Pain Syndrome — Completed
- Study of AA4500 in the Treatment of Peyronie's Disease — Completed
- Efficacy and Safety of Leuprolide Acetate 22.5 mg Depot in Treatment of Prostate Cancer — Completed